Back to Insider Trading View Full Company Profile

CNVS

HEALTHY

Cineverse Corp.

CIK: 0001173204

Strong Buy (70% confidence)

Last activity: Feb 17, 2026

Financial Metrics

As of Mar 31, 2025 (10-K)

Revenue $78.18M
Net Income $3.76M
Total Cash $13.94M
Total Debt $25.66M
Current Ratio 1.11

Trend Signals

CEO Buy STRONG

CEO buying activity

Feb 17, 2026

CFO Buy STRONG

CFO buying activity

Feb 17, 2026

Insider Roster (7 total, 7 active)

Insider Buys Sells Net Value Holdings
MCGURK CHRISTOPHER J
CEO and Chairman
1 0 $150K
178,526 shares
$357K
Huidor Mark Antonio
Pres Tech/Chief Product Off
1 0 $75K
190,061 shares
$380K
Lindsey Mark Wayne
CFO
1 0 $70K
154,168 shares
$308K
Macias Yolanda
Chief Motion Pictures Officer
1 1 $55K
121,760 shares
$244K
OPEKA ERICK
CSO and President
1 0 $60K
224,146 shares
$448K
LOFFREDO GARY S
CLO, Secretary and Sr Advisor
1 0 $60K
200,337 shares
$401K
Torres Mark
Chief People Officer
1 0 $50K
183,274 shares
$367K

Recent Transactions

BUY MCGURK CHRISTOPHER J (CEO and Chairman)

75,000 shares @ $2.00

$150K

Feb 17, 2026

Conviction: | View SEC Filing →
BUY Huidor Mark Antonio (Pres Tech/Chief Product Off)

37,500 shares @ $2.00

$75K

Feb 17, 2026

Conviction: | View SEC Filing →
BUY Lindsey Mark Wayne (CFO)

35,000 shares @ $2.00

$70K

Feb 17, 2026

Conviction: | View SEC Filing →
BUY Macias Yolanda (Chief Motion Pictures Officer)

30,000 shares @ $2.00

$60K

Feb 17, 2026

Conviction: | View SEC Filing →
BUY OPEKA ERICK (CSO and President)

30,000 shares @ $2.00

$60K

Feb 17, 2026

Conviction: | View SEC Filing →
BUY LOFFREDO GARY S (CLO, Secretary and Sr Advisor)

30,000 shares @ $2.00

$60K

Feb 17, 2026

Conviction: | View SEC Filing →
BUY Torres Mark (Chief People Officer)

25,000 shares @ $2.00

$50K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Macias Yolanda (Chief Motion Pictures Officer)

2,189 shares @ $2.42

$5K

Dec 2, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.